Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5' DFUR)on Breast Cancer

Breast Cancer

Volumn 7, Issue 1, 2000, Pages 37-41

  Hata, Yoshinobu ^a   Takahashi, Hiromasa ^b   Sasaki, Fumiaki ^b   Ogita, Masami ^c   Uchino, Junichi ^d   Yoshimoto, Masanori ^e   Akasaka, Yoshinobu ^f   Nakanishi, Yoshimi ^g   Sawada, Yasuo ^h  

^a Sapporo Social Insurance   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO CANCER CENTER   (Japan)

^d KUSHIRO ROSAI HOSPITAL   (Japan)

^e Otaru Municipal Hospital   (Japan)

^f Konan Hospital   (Japan)

^g Sapporo Municipal Hospital   (Japan)

^h Tenshi Hospital   (Japan)

Author keywords

5' Deoxy 5 fluorouracil; Breast cancer; Pyrimidine nucleoside phosphorylase

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DOXIFLURIDINE; FLOXURIDINE; FLUOROURACIL; GLYCOSYLTRANSFERASE; MITOMYCIN; PRODRUG; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; PYRIMIDINE-NUCLEOSIDE PHOSPHORYLASE; TAMOXIFEN; THYMIDINE PHOSPHORYLASE; TUMOR PROTEIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BIOTRANSFORMATION; BREAST TUMOR; DISEASE FREE SURVIVAL; ENZYMOLOGY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; MENOPAUSE; METABOLISM; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOTRANSFORMATION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE-FREE SURVIVAL; FEMALE; FLOXURIDINE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MENOPAUSE; MIDDLE AGED; MITOMYCIN; NEOPLASM PROTEINS; PENTOSYLTRANSFERASES; PRODRUGS; TAMOXIFEN; THYMIDINE PHOSPHORYLASE; TREATMENT OUTCOME;

EID: 0033654285     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967186     Document Type: Article

References (13)

1. Ishitsuka H, Miwa M, Takemoto K, et al: Role of uridine phosphorylase for antitumor activity of 5 L deoxy-5-fluorouridine. Jpn J Cancer Res 71:112-123, 1980. (Pubitemid 10100453)
2. Suzuki S, Hongu Y, Fukazawa H, et al: Tissue distribution of 5Ldeoxy-5-fluorouridine and derivated 5-furuorouracil in tumor. Jpn J Cancer Res 71:238-245, 1980.
3. Furukawa K, Yoshimura A, Sumizawa T, et al: Angiogenic factor. Nature 356:668, 1992.
4. Usnki K, Saras J, Waltenberger J, et al: Platelet-defived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 184:1311-1316, 1992.
5. Takahashi H, Uchino J, Ogita M, et al: Pyrimidine nucleoside phosphorylase activity and biological characteristics of breast cancer. Int J Oncol 7:1139-1144, 1995. (Pubitemid 26023138)
6. Peters GJ, Wets M, Keepers YPAM, et al: Transformation of mouse fibroblasts with the oncogenes Hras or trk is associated with pronounced changes in drug sensitivity and metabolism. Int J Cancer 54:250-455, 1993.
7. Haraguchi M, Furukawa T, Sumizawa T, et al: Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53:5680-5682, 1993. (Pubitemid 23360271)
8. Eda H, Fujimoto K, Watanabe S, et al: Cytokines induced uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5T-deoxy-5-fluorouridine. Jpn J Cancer Res 84:341-347, 1993. (Pubitemid 23104320)
9. Iida Y, Tokuda Y, Arai K, et al: Measurement of cytosol estrogen receptor in human breast cancer using 16a -125-estradiol. Nucl Med 24:327-333, 1987.
10. Kobayashi S, Iwase H, Karamatsu S, et al: Fundamental and clinical studies on the monoclonal EIA kit for the measurement of progesterone recepteor (PgR) in human breast cancer tissues. Morro Clinic 36:277-281, 1988.
11. Uchino J, Samejima N, Tanabe T, et al: Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Br J Cancer 69:767-771, 1994. (Pubitemid 24112703)
12. Toi M, Hoshina S, Taniguchi T, et al: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64:79-82, 1995.
13. Yamamoto Y, Toi M, Tominaga T: Prediction of the effect of 5W-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients. Oncol Report 3:863-865, 1996. (Pubitemid 26323740)